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Abstract
Most intrinsic death signals converge into the activation of pro-apoptotic BCL-2 family members BAX and BAK at the
mitochondria, resulting in the release of cytochrome c and apoptosome activation. Chronic endoplasmic reticulum (ER)
stress leads to apoptosis through the upregulation of a subset of pro-apoptotic BH3-only proteins, activating BAX and BAK
at the mitochondria. Here we provide evidence indicating that the full resistance of BAX and BAK double deficient (DKO)
cells to ER stress is reverted by stimulation in combination with mild serum withdrawal. Cell death under these conditions
was characterized by the appearance of classical apoptosis markers, caspase-9 activation, release of cytochrome c, and was
inhibited by knocking down caspase-9, but insensitive to BCL-XL overexpression. Similarly, the resistance of BIM and PUMA
double deficient cells to ER stress was reverted by mild serum withdrawal. Surprisingly, BAX/BAK-independent cell death did
not require Cyclophilin D (CypD) expression, an important regulator of the mitochondrial permeability transition pore. Our
results suggest the existence of an alternative intrinsic apoptosis pathway emerging from a cross talk between the ER and
the mitochondria.
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Introduction
Apoptosis is a conserved cell death mechanism essential for
normal development and tissue homeostasis in multicellular
organisms. Although apoptosis presumably participates in the
development of most cell lineages, alterations in the expression of
apoptosis-regulatory proteins is implicated in the initiation of a
variety of human diseases, including autoimmunity, immunodefi-
ciency, cancer, and neurodegenerative diseases, among others
[1,2]. The BCL-2 family of proteins is a group of upstream
regulators of the caspase cascade, comprised of both pro- and anti-
apoptotic components [1,2]. BCL-2 family members are defined by
the presence of up to four a-helical conserved BCL-2 homology
(BH) domains. Pro-apoptotic BCL-2 family members can be
further subdivided into more highly conserved, ‘‘multidomain’’
members displaying homology in the BH1, BH2 and BH3 domains
(i.e. BAX and BAK), and the ‘‘BH3-only’’ members which contain
a single BH domain critical for activation of apoptosis.
Genetic and biochemical studies indicate that BAX and BAK
function in concert as a major core of the intrinsic apoptosis
pathway at the mitochondria [3,4]. Upstream BH3-only proteins
respond to particular apoptotic signals and subsequently trigger
the conformational activation of BAX and BAK, inducing their
intramembranous homo-oligomerization and resultant mitochon-
drial outer membrane permeabilization (MOMP) [5]. MOMP is a
key step for the release of cytochrome c and the assembling of the
apoptosome [5,6]. Besides, the BH3-only proteins can be
functionally separated into two subtypes: (i) activators (i.e. tBID,
BIM, and PUMA) that directly engage BAX and BAK to trigger
cytochrome c release, but are sequestered by anti-apoptotic BCL-2
molecules; and (ii) sensitizers or inactivators (i.e. BAD and NOXA)
that only bind to and antagonize anti-apoptotic BCL-2 members
to release activator BH3-only proteins (examples in [7–11]).
Alternatively, differential binding to anti-apoptotic proteins may
explain the action of activator and sensitizer/inactivator BH3-only
proteins [12] or combination of both models [11,13,14].
Under certain conditions, cytochrome c release occurs inde-
pendent of BAX and BAK through opening of the mitochondrial
permeability transition pore (PTP), a non-specific pore in the inner
mitochondrial membrane (see reviews in [15–17]). Opening of the
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.PTP is observed under conditions of mitochondrial calcium
overload, especially when accompanied by oxidative stress,
elevated phosphate concentrations and adenine nucleotide deple-
tion, enabling free passage into the mitochondria of molecules of
,1.5 kDa [15–17]. Opening of the PTP leads to dissipation of the
mitochondrial transmembrane potential (DYm) and an influx of
solutes. This causes expansion of the matrix, resulting in sufficient
swelling to rupture the outer mitochondrial membrane and
cytochrome c release. However, dissipation of DYm can also lead
to a sudden decrease in ATP levels, triggering necrotic cell death.
Although the molecular identity of PTP remains uncertain,
different components are proposed including voltage-dependent
anion channel (VDAC), the adenine nucleotide translocator, the
mitochondrial phosphate carrier, and Cyclophilin D (CypD), a
cyclosporin A target [15–17]. Studies using knockout cells for
putative components of the PTP confirmed only a functional role
for CypD in PTP-mediated cell death in vitro and in vivo as we and
other described [18–21]. Remarkably, physical interactions
between BCL-2 family members and components of the PTP
are also reported, suggesting that BCL-2-related proteins may
facilitate PTP under certain conditions, possibly forming mixed
protein complexes with membrane permeabilizing activities
(reviewed in [17]).
Interestingly, Y. Tsujimoto’s group reported the engagement of
apoptosome dependent apoptosis that was independent of the
expression of BAX, BAK and CypD, a phenomena initiated when
deathstimulationwasinducedbythesimultaneousexposureofcells
arachidonic acid and the ionophore A23187 [22], stimuli known to
alterendoplasmicreticulum(ER)calciumhomeostasisamongother
effects.CelldeathafterarachidonicacidandA23187treatmentwas
dependentontheactivityofanunknownserineprotease.Inaddition
tooperateasamajorcalciumreservoirofthecell,theERservesasa
specialized compartment for protein folding along the secretory
pathway.Anumberofconditionsinterferewithproteinfoldingatthe
ER lumen leading to the accumulation of unfolded or misfolded
proteins, a cellular condition referred to as ‘‘ER stress’’ [23]. Cells
adapt to ER stress through the engagement of the Unfolded Protein
Response (UPR), an integrated signaling pathway that controls
protein folding at the ER [24,25].
Under chronic ER stress conditions, cells undergo apoptosis
mediated by the activation of BAX and BAK at the mitochondria
[26]. BAX and BAK double deficient (DKO) cells [3,27,28] and
conditional DKO mice [29] are highly resistant to death stimuli
dependent on ER injuries. ER stress-induced apoptosis is initiated
by the activation of several BH3-only protein including BIM,
PUMA and NOXA, and is antagonized by the expression of BCL-
2 or BCL-XL [10,30,31]. In this article, we provide evidence
indicating the occurrence of cytochrome c release and caspase-9-
dependent apoptosis in BAX and BAK DKO cells when ER stress
is stimulated in combination with mild serum withdrawal.
Interestingly, BAX and BAK-independent cell death did not
require CypD expression, did not involve mitochondrial swelling,
and was insensitive to serine protease inhibitors. Our results are
indicative of the existence of an alternative intrinsic cell death
pathway that is independent of BAX/BAK and CypD expression
that possibly triggers apoptosome-mediated cell death.
Results
Mild Serum Withdrawal Recovers the Susceptibility of
BAX and BAK DKO Cells to ER Stress-induced Cell Death,
but Not to other Intrinsic Death Stimuli
We previously reported an impaired ability of BAX and BAK
DKO murine embryonic fibroblasts (MEFs) to activate the ER
stress sensor IRE1a, associated with diminished downstream
cJun-N terminal kinase (JNK) signaling [29]. To assess the
impact of BAX and BAK deficiency on JNK phosphorylation in
that study, we stimulated cells in the presence of low serum
concentrations (0.5–2% serum) for 2 h to decrease basal
phosphorylation levels, and then exposed cells with the ER
stress agent tunicamycin (Tm, inhibitor of N-linked glycosyla-
tion). Interestingly, when cells were cultured under these
conditions for prolonged time (.16 h), we noticed morphological
changes reminiscent of apoptosis in BAX and BAK DKO cells,
including the appearance of blebs at the cell surface, cell
shrinkage and detachment from the cell culture plate (Figure 1A
and 1B. C. Hetz and S.J. Korsmeyer, 2004, unpublished
observations).
To further characterize the death mechanism of BAX and BAK
DKO cells under combined stimulation of ER stress and mild
serum withdrawal, cells were treated with a panel of drugs that
perturb ER homeostasis including Tm, brefeldin A (an inhibitor of
ER to Golgi trafficking), or thapsigargin (Thap, inhibitor of the ER
calcium ATPase SERCA) in the presence of regular cell culture
media containing 10% serum or pre-treated for 2 h with media
containing 0.5% serum. After 24 h, relative cell number was
monitored with the MTS assay. To our surprise, resistance of
BAX and BAK DKO cells to ER stress was reverted when
stimulation was performed under conditions of mild serum
withdrawal (Figure 1C-E and Figure S1). Serum withdrawal alone
did not induce cell death of BAX and BAK DKO cells, even after
three days of treatment (not shown) as previously described [3].
Similar results were observed when cell death was monitored using
propidium iodide (PI) staining and FACS analysis (Figure 1F).
In order to define whether mild serum withdrawal sensitizes
DKO cells to other intrinsic death stimuli, cells were treated with a
variety of pro-apoptotic agents that are non-ER stress related.
These include etoposide (DNA damage agent), taxol and
nocodazole (both alter microtubule dynamics), and actinomycin
D (an inhibitor of protein synthesis). Unexpectedly, the resistance
of BAX/BAK DKO cells to each of these pro-apoptotic agents
was not reverted by mild serum withdrawal (Figure 1G). Similarly,
serum withdrawal did not enhance the susceptibility of BAX/BAK
DKO cells to engagement of death receptors since a similar rate of
cell death was observed after treatment with TNFa when
compared to control cells grown in the presence of 10% serum
(,80% cell death, not shown). These results suggest that
combinatorial stimulation between ER stress and mild serum
withdrawal engages a BAX/BAK-independent cell death path-
way.
Caspase-dependent Apoptosis in BAX and BAK DKO Cells
Undergoing ER Stress in Conjunction with Serum
Withdrawal
To determine the mechanism involved in the death of BAX/
BAK DKO cells undergoing ER stress under mild serum
withdrawal conditions, we performed Annexin-V-FITC and PI
staining. As previously described [3,27,28], DKO cells grown in
cell culture media containing 10% serum were completely resistant
to apoptosis induced by ER stress (Figure 2A). Reconstitution of
DKO cells with mitochondria-located BAX restored the sensitivity
of these cells to Tm-mediated cell death (Figure 2A, left panel),
confirming the requirement of BAX expression at the mitochon-
dria to initiate apoptosis by ER-related injuries [27]. BAX and
BAK DKO cells exposed to Tm or Thap in conjunction with mild
serum withdrawal underwent apoptosis measured after Annexin-
V-FITC staining (Figure 2A, right panel).
A BAX/BAK/CypD-Independent Intrinsic Death Pathway
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e37782Figure 1. Serum withdrawal recovers the susceptibility of BAX and BAK DKO cells to ER stress-induced cell death. (A) Expression levels
of BAX and BAK were determined in murine embryonic fibroblast from wild type (WT), BAX or BAK single knockout (KO) or BAX and BAK DKO (DKO)
cells by Western blot. As a loading control actin levels was determined. (B) Phase contrast images of BAX/BAK DKO cells treated or not (NT) with
10 mg/ml Tm for 16 h in cells pre-exposed for 2 h to cell culture media containing 0.5% serum. (C) BAX and BAK DKO MEFs were treated with
indicated concentrations of Tm, (D) Brefeldin A or (E) Thap in cells grown in regular cell culture media or pre-treated in media containing 0.5% serum
for 2 h. WT cells grown in media containing 0.5% serum were monitored as control (see additional controls in Figure S1). After 24 h of treatment, cell
viability was analyzed with the MTS assay. Mean and standard deviations are presented of triplicates of a representative experiment. (F) BAX and BAK
DKO cells were pre-incubated for 2 h in cell culture media containing 0.5% serum or grown with regular cell culture media (10% serum), and then
treated with a panel of different intrinsic death stimuli, including 10 mg/ml Tm. Untreated cells (NT) were used as control. After 24 h of treatment cell
death was monitored by propidium iodide (PI) staining and FACS analysis. Results represent average and standard deviation of six independent
experiments. Student’s T-test was used to analyze statistical significance between cells treated with Tm in the presence of 10% or 0.5% serum. (***:
p,0.001). (G) Alternatively, cells were analyzed as described in F and treated with 20 mM etoposide (Eto), 1 mM taxol (Tax), 10 mM nocodazole (Noc),
10 mg/ml actinomycin D (Act D) or 0.1 mM staurosporine (Sts). Results represent average and standard deviation of 4 independent experiments.
Student’s T-test was used to analyze statistical significance between cells treated with these drugs in the presence of 10% or 5% of serum (*: p,0.05;
***: p,0.001).
doi:10.1371/journal.pone.0037782.g001
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e37782Figure 2. BAX and BAK double deficient cells undergo caspase-dependent apoptosis under conditions of ER stress in conjunction
with serum withdrawal. (A) Left panel: WT, BAX/BAK DKO cells or DKO cells stably reconstituted with mitochondrial-targeted BAX (mtBAX) were
treated with 10 mM Thap or 10 mg/ml Tm under normal growing conditions (10% serum). After 12 h, apoptosis was monitored by Annexin-V-FITC and
PI staining followed by FACS analysis. Mean and standard deviations are presented of three determinations. Right panel: Alternatively, experiments
were performed in cells pre-treated for 2 h with cell culture media containing 0.5% serum, followed by the addition of ER stress agents. (B) BAX/BAK
DKO cells were exposed to 10 mM Thap in the presence of cell culture media containing 10% serum or pretreated in media containing 0.5% serum,
and then cells were stained with Hoechst to visualize nuclear morphology by fluorescent microscopy. (C) Cell morphology was monitored in BAX/
BAK DKO cells treated with Tm for 12 h or 16 h under normal growing conditions or in cells pretreated for 2 h with media containing 0.5% serum.
Untreated (NT) cells are also presented as control. Red arrowheads indicate classical apoptosis morphological features including chromatin
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BAK DKO cells treated with Tm under mild serum withdrawal by
the visualization of chromatin condensation and fragmentation by
nuclear staining with Hoechst (Figure 2B). We also detected
ultrastructural features of apoptosis under our experimental
conditions using electron microscopy (EM), associated with the
appearance of condensed and fragmented nuclei, in addition to
cell shrinkage (Figure 2C). Consistent with these results, a strong
activation of caspase-3 was detected using immunofluorescence
when DKO cells were co-stimulated with Tm and low serum
concentrations (Figure 2D). Minimal activation of caspase-3 was
detected in DKO cells treated with Tm under normal growing
conditions (Figure 2D).
In order to test the possible involvement of caspases in the death
of BAX and BAK DKO cells, we pre-incubated cells with the pan-
caspase inhibitor zVAD-fmk for 30 minutes before treatment with
Tm or Thap in the presence of 0.5% serum in the cell culture
media. zVAD-fmk treatment drastically reduced the levels of
Annexin-V-FITC staining and cell shrinkage observed in DKO
cells (Figure 2E). Cell shrinkage was also observed by FACS
analysis of DKO cells reflected on a decrease in the forward side
scattering (FSC) parameter, which directly correlated with the
levels of phosphatidylserine exposure at the cell surface (Figure 2F).
Thus, mild serum withdrawal fully reverts the resistance of BAX
and BAK DKO cells to ER stress-mediated apoptosis.
Cell Death in BAX and BAK DKO Cells is Associated with
Cytochrome c Release, a Drop in DYm, and is Mediated
by Caspase-9
To define the potential involvement of mitochondria in the
occurrence of BAX/BAK-independent apoptosis, we first mea-
sured DYm in cells undergoing ER stress. As expected, whereas
WT MEFs presented a clear drop on DYm after Tm treatment,
BAX/BAK DKO cells showed no decrease on DYm as
determined by DIOC8(3) staining and FACS analysis (Figure 3A).
This phenotype was partially reverted by performing treatments
with Tm in conjunction with serum withdrawal (Figure 3A). To
further examine the contribution of mitochondria in the cell death
process, we visualized the distribution of cytochrome c in BAX/
BAK DKO cells by immunofluorescence. As shown in Figure 3B,
cytochrome c redistribution was observed in DKO cells treated
with Tm in conjunction with serum withdrawal, resulting in the
partial loss of the punctuate pattern characteristic of mitochon-
dria-located cytochrome c into a more diffuse cytoplasmic pattern
(Figure 3B). Quantification of four independent experiments
revealed a significant reduction in the Manders co-localization
index between cytochrome c and a mitochondrial tracker when
ER stress was stimulated in conjunction with mild serum
withdrawal (Figure 3C). Moreover, at the population level, around
60% of BAX/BAK DKO cells presented cytochrome c redistri-
bution using this imaging analysis after ER stress and serum
withdrawal stimulation (Figure 3D).
We then monitored the possible assembly of the apoptosome by
monitoring the activation of caspase-9 using immunofluorescence
using a specific antibody against active caspase-9. A consistent
activation of caspase-9 was detected in most BAX and BAK DKO
cells when treated with Tm and low serum concentration in terms
of signal intensity or percentage of positive cells (Figure 3E). To
define the functional contribution of the canonical mitochondrial-
apoptotic pathway in the death of BAX/BAK DKO cells, we
knocked down the expression of pro-caspase-9 using stable
delivery of a short hairpin RNA (shRNA) with lentiviral vectors,
which only partially reduced pro-caspase-9 levels (Figure 3F). As
control, an shRNA construct against luciferase mRNA was
employed. Knocking down pro-caspase-9 expression significantly
decreased the rate of cell death observed in BAX/BAK DKO cells
treated with Tm in conjunction with serum withdrawal (Figure 3F,
right panel). As additional control, we also tested the possible
contribution of caspase-8 to the death process of BAX/BAK DKO
cells. Cells were pre-incubated with 40 mM of the caspase-8
inhibitor z-IETD-fmk for 30 min, and the levels of cell death were
evaluated by FACS. z-IETD-fmk did not significantly reduce ER
stress-induced apoptosis under conditions of mild serum with-
drawal (Figure 3G). In contrast, z-IETD-fmk efficiently blocked
FasL-induced apoptosis in BAX/BAK DKO cells (Figure 3G).
Together, these results suggest an active role of the apoptosome in
the death of BAX and BAK DKO cells after stimulation of ER
stress in the presence of mild serum withdrawal.
Cell Death in BAX and BAK DKO Cells is Insensitive
to BCL-XL Overexpression
Anti-apoptotic BCL-2 family members are potent inhibitors of
intrinsic cell death by antagonizing BH3-only proteins. We stably
transduced BAX and BAK WT and DKO cells with retroviruses
expressing BCL-XL or the empty vector (Figure 4A) and then
assessed their susceptibility to cell death after ER stress/mild
serum withdrawal stimulation. As expected, BCL-XL overexpres-
sion dramatically protected WT cells against ER stress-mediated
apoptosis (Figure 4B, left panel). However, no reduction in the
amount of cell death was observed in BAX/BAK DKO cells
overexpressing BCL-XL after 24 h of treatment with Tm in
conjunction with serum withdrawal (Figure 4B). Similarly, time
course analysis revealed a similar kinetic of cell death in BAX and
BAK DKO control and BCL-XL overexpressing cells (Figure 4B).
In agreement with these results, BCL- XL overexpression did not
alter the release of cytochrome c in BAX/BAK DKO cells
exposed to similar conditions (Figure 4C), which was confirmed
after quantification and statistical analysis (Figures 4D and S2A).
In addition to BAX and BAK, the pro-apoptotic multidomain
protein, BCL-2 Ovarian Killer (BOK), remains poorly character-
ized [32]. We monitored the levels of bok mRNA in WT and
BAX/BAK DKO MEFs by quantitative RT-PCR. A very low
abundance of bok mRNA was observed at basal levels in MEFs,
which was not altered under conditions of ER stress and serum
condensation and fragmentations. In addition cell shrinkage is observed in the analysis. N: nucleus. (D) BAX/BAK DKO cells were exposed to 10 mg/ml
Tm in the presence of cell culture media containing 10% serum (top panel) or pretreated in media containing 0.5% serum (Botton panel). After 10 h,
active caspase 3 (green) was evaluated by indirect immunofluorescence. To visualize cells, actin was monitored with Phalloidin-Rhodamine staining,
and nuclei were stained with Hoechst (blue). Images were acquired with a confocal microscope and represent the result of four independent
experiments. Left panel: Quantification of the levels of active caspase-3 per cell by measuring fluorescent pixel intensity/area (A.U.) or the percentage
of cells with positive active caspase-3 signal over a cutoff definer in non treated cells. Mean and standard deviation is presented of four experiments.
Student’s T-test was used to analyze statistical significance between both groups (*: p,0.05; ***: p,0.001). (E) BAX/BAK DKO cells were pretreated for
30 min with 10 mM zVAD-fmk or left untreated in media containing 10% or 0.5% serum (pre-incubation of 2 h), and then exposed to 10 mg/ml Tm or
10 mM Thap. After 12 h, Annexin-V-FITC staining was evaluated by FACS analysis. Mean and standard deviation is presented of three determinations.
(F) In parallel, the correlation between Annexin-V-FITC staining and cell shrinkage was evaluated by FACS by monitoring forward scatter parameter in
cells described in (E). Data represent the results of three independent experiments.
doi:10.1371/journal.pone.0037782.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37782Figure 3. ER stress triggers cytochrome c redistribution and caspase-9-dependent cell death. (A) WT and BAX/BAK DKO cells were
treated with 10 mg/ml Tm or left untreated (NT) in regular cell culture media or in cells pre-treated with media containing 0.5% serum for 2 h. After
8 h of treatment, DYm was determined by DIOC8(3) staining and FACS analysis. (B) BAX/BAK DKO cells were exposed to 10 mg/ml Tm in the presence
of cell culture media containing 10% serum (top panel) or pre-treated with media containing 0.5% serum (Botton panel). After 10 h, cells were
stained with Mitotracker orange (red), fixed and cytochrome C (Cyt C, green) distribution visualized by indirect immuofluorescence. DNA was stained
with Hoechst (blue). Images were acquired by confocal microscopy and are representative of four independent experiments. Scale bar is 25 mm. (C)
Quantification of the Manders colocalization coefficient MTO/CytC (fraction of mitrotracker orange signal in co-localizing with cytochrome C signal) or
CytC/MTO (fraction of the cytochrome C co-localizing mitotracker orange). Student’s T-test was used to analyze statistical significance (*: p,0.05).
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e37782withdrawal (Figure S3). As positive control we monitored ovarian
tissue (Figure S3) [33,34].
The Resistance of BIM and PUMA Double Deficient Cells
to ER Stress-mediated Apoptosis is Reverted by Mild
Serum Withdrawal
BIM, PUMA and NOXA, are strongly induced at the
transcriptional level in cells undergoing prolonged ER stress,
and cells deficient for these genes are partially resistant to ER
stress-related injuries [30,35], whereas bim and puma double
deficiency drastically protects against ER stress [11]. Based on
these findings, we studied the potential role of BIM and PUMA
on ER stress-mediated cell death under conditions of mild
serum withdrawal. After confirming the upregulation of BIM,
PUMA, and NOXA mRNA levels in MEFs undergoing ER
stress (Figure 4E), we then investigated the functional role of
BIM and PUMA on cell death using a gene ablation approach.
BIM or PUMA single knockout cells were slightly resistant to
Tm treatment when compared with WT control cells
(Figure 4F). In sharp contrast, BIM and PUMA DKO cells
were highly resistant to mild concentrations of Tm (Figure 4F),
similar to the phenotype described in BAX/BAK DKO cells.
Interestingly, the protective effects of bim and puma ablation
were fully reverted when cell death stimulation was performed
together with mild serum withdrawal (Figure 4G).
It has be been suggested that the BH3-only protein BAD has
pro-apoptotic activities independent of BAX/BAK [36]. To
complement our experiments, we determined the possible pro-
apoptotic effects of BH3-only proteins after enforced expression in
BAX/BAK DKO MEFs under conditions of serum withdrawal.
Using the pMIG-GFP bicistronic retroviral system, we transiently
expressed a full panel of different BH3-only proteins including
tBID, BIM, PUMA, NOXA, and BAD (Figure 4H). As previously
reported [7,37], the overexpression of the activator BH3-only
proteins tBID, BIM and PUMA triggers cell death in WT MEFs,
which was dependent on the expression of BAX and BAK,
whereas overexpression of NOXA and BAD did not affect cell
viability (Figures 4H, S2B and S2C). No cell death was observed
after the expression of these BH3-only proteins in BAX/BAK
DKO cells when serum in the cell culture was decreased to 0.5%
(Figure 4G). We controlled the efficiency of retroviral transduction
in all the experiments by monitoring GFP expression by FACS
analysis, which was in the range of ,40–60% efficiency (Figure
S3B). Taken together, these results suggest that BH3-only proteins
are not involved in the occurrence of BAX/BAK-independent
apoptosis in our experimental system.
Assessment of the Contribution of UPR Signaling in the
Death of BAX and BAK DKO Cells
Based on the observation that mild serum withdrawal specif-
ically restores the susceptibility of BAX/BAK DKO cells to ER
stress-mediated apoptosis and not other intrinsic death stimuli
(Figure 1G), we rationalized that signals emerging from the ER
may regulate the engagement of mitochondrial-mediated apopto-
sis. To test this hypothesis we first analyzed the kinetics and
intensity of early UPR signaling in WT and BAX/BAK DKO
cells. Cells were exposed to Tm in the presence or absence of
serum withdrawal, and the expression of major proximal UPR
transcription factors, XBP-1 and ATF4, or the downstream
transcription factor CHOP/GADD153 [24,25], were followed
over time by Western blot analysis. We did not observe any
significant alteration of the kinetic of UPR signaling in DKO cells
treated with 10 mg/ml Tm in the presence or absence of serum
withdrawal (Figure 5A). This result is in agreement with our recent
finding indicating that the regulation of XBP-1 expression by BAX
and BAK or BH3-only proteins is lost when cells are treated with
high Tm concentrations [38,39]. More importantly, these results
indicate that the intensity of ER stress is not altered by the serum
withdrawal condition as monitored by the kinetics and amplitude
of UPR signaling.
Activation of the UPR stress sensor IRE1a has been linked to
ER stress-induced apoptosis through engagement of the JNK
pathway [40,41]. Treatment of cells with the selective JNK
inhibitor SP600125 did not attenuate the rate of apoptosis of
DKO cells exposed to Thap or Tm together with serum
withdrawal (Figure 5B). Another death kinase, Glycogen Synthase
Kinase-3 beta (GSK3-b), regulates ER stress-mediated apoptosis
under certain conditions [42,43]. Pre-treatments with two different
GSK3-b inhibitors (TDZD-8 and L803-mts) did not affect the
survival of BAX and BAK DKO cells undergoing ER stress in
conjunction with mild serum withdrawal (Figure 5B).
Sustained activation of the ER stress sensor PERK triggers
apoptosis [26,44–47], whereas early signaling events promote cell
protection [48,49]. We knocked down PERK expression with
shRNA and assessed the impact on cell death. An efficient down
regulation of PERK was observed, reflecting an attenuation of
PERK phosphorylation and the expression of ATF4 and CHOP/
GADD153 (Figure 5C). Cell death induced by Tm treatment
combined with serum withdrawal was significantly enhanced by
targeting PERK expression (Figure 5D). This result suggest that
UPR signaling modulates in part the occurrence of BAX and
BAK-independent cell death after stimulation of ER stress under
conditions of mild serum withdrawal.
(D) Quantification of the percentage of cells with redistributed cytochrome C (CytC) experiments described in C (***: p,0.001). (E) Left panel: BAX/
BAK DKO cells exposed to 10 mg/ml Tm for 10 h in the presence of cell culture media containing 10% (top panel) or 0.5% (bottom panel) serum were
fixed and active caspase 9 (green) was evaluated by indirect immunofluorescence. Actin was monitored with Phalloidin-Rhodamine (red) and nuclei
were stained with Hoechst (blue). Images are representative of four independent experiments. Scale bar is 25 mm. Right panel: Quantification of
active caspase 3 fluorescence per cell (Arbitrary units: A.U.) and the percentage of active-caspase 3-positive cells. Data represents mean and standard
deviation of four independent experiments performed in duplicates. Student’s T-test was used to calculate statistical significance (*: p,0.05; ***:
p,0.001). (F) BAX and BAK DKO cells were stably transduced with a lentiviral vector expressing an shRNA against pro-caspase-9 mRNA (shCaspase-9)
or a control shRNA against the luciferase mRNA (shLuc), and pro-caspase-9 protein levels were determined by Western blot. HSP90 levels were
monitored as loading control. Then, the cells were treated with 10 mg/ml Tm in cells grown under normal cell culture media or pre-treated for 2 h
with media containing 0.5% serum. Cell death was determined after 24 h by PI staining and FACS analysis. Data represents mean and standard
deviation of three independent experiments performed in duplicates. Student’s T-test was used to analyze statistical significance between shLuc and
shCaspase-9 cells treated with Tm (*: p,0.05; n.s.: no significant). (G) BAX and BAK DKO cells were pre-incubated in media containing 0.5% serum for
2 h. Then, the cells were exposed to 10 mg/ml Tm for 24 h in present or absence of 25 mM z-IETD-fmk (caspase-8 inhibitor). As positive control, DKO
cells were exposed to 1 mg/ml Fas ligand (FasL) as positive control of working Z-IETD-FMK. The cell death was monitored by propidium iodide (PI)
staining and FACS analysis. Results represent average and standard deviation of three independent experiments. Student’s T-test was used to analyze
statistical significance (**: p,0.01; n.s.: no significant).
doi:10.1371/journal.pone.0037782.g003
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e37782Figure 4. BAX and BAK-independent cells death induced by ER stress and serum withdrawal is not affected by BCL-XL
overexpression or by BH3-only proteins. (A) WT and BAX/BAK DKO MEFs were stably transduced with retroviruses expressing human BCL-XL or
empty vector (Mock) and the expression levels of BCL-XL was evaluated by Western blot analysis. As loading control, HSP90 levels were determined.
(B) Then the susceptibility of cells presented in (A) to cell death was assessed after treatments with 10 mg/ml Tm in cells pretreated in cell culture
media containing 0.5% serum for 2 h or grown with regular cell culture media. Cell death was monitored by PI staining and FACS analysis at 16, 20
and 24 h. Mean and standard deviation is presented of three independent experiments. Two-way ANOVA was used to analyze statistical significance
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e37782between MOCK and BCL-XL cells (***: p,0.001). (C) Cells described in A were treated with 20 mg/ml Tm in the presence of cell culture media
containing 10% serum (top panel) or pre-treated with media containing 0.5% serum (Botton panel). After 10 h, cells were stained with Mitotracker
orange (red), fixed and cytochrome C distribution visualized by indirect immunofluorescence (Cyt C, green). DNA was stained with Hoechst (blue).
Images were acquired by confocal microscopy and are representative of four independent experiments. Scale bar is 25 mm. (D) Quantification of the
percentage of cells with redistributed cytochrome C (CytC) experiments described in C (**: p,0.01). (E) The mRNA levels of bim, puma and noxa were
analyzed by semi-quantitative RT-PCR in total cDNA from MEFS treated with 10 mg/ml Tm for indicated time points. Beta-actin levels were determined
as loading control. (E) WT, BIM KO, PUMA KO, and BIM and PUMA double deficient (DKO) cells were treated with 0.5 mg/ml Tm for 24 h, and then cell
death was evaluated after PI staining and FACS analysis. Data represents two independent experiments performed in triplicates. Mean and standard
deviation is presented of a representative experiment. (F) BIM and PUMA DKO cells and parental WT controls cells were treated with indicated
concentrations of Tm as described in (E). After 24 h, apoptosis was determined by quantifying cells with hypo-diploid DNA content after PI staining of
permeabilized cells and FACS analysis. Mean and standard deviation is presented. (G) WT and BAX/BAK DKO cells were transduced with pMIG-GFP
retroviruses expressing tBID-HA, BIM-HA, PUMA-HA, NOXA-HA, BAD-HA, or empty vector (MOCK). After 8 h of viral transduction, serum in the culture
media was decreased to 0.5% or replaced by media containing 10% serum. Then, cell viability was analyzed after 24 h by PI staining and FACS
analysis. Transduction efficiency in each experiment was monitored by detecting GFP expression by FACS in the same experiments (example in
Figure S2). Data is the average and standard deviation of three independent experiments. p value to compare the rate of cell death in WT cells
transduced with BH3-only protein-expressing viruses versus a MOCK transduced WT cells were calculated by Student’s t-test (*: p,0.05; **: p,0.001;
n.s.: non significant). Comparison between DKO cells transduced with retroviruses in the presence or absence of serum were in all cases non
significant.
doi:10.1371/journal.pone.0037782.g004
Figure 5. UPR signaling in BAX/BAK DKO cells undergoing ER stress and mild serum withdrawal conditions. (A) WT and BAX/BAK DKO
cells were treated with 10 mg/ml Tm under regular growing conditions or in cells pre-incubated for 2 h with media containing 0.5% serum. After
indicated time points, the expression levels of the UPR transcription factors XBP-1, ATF4 and CHOP were assessed by Western blot analysis. As control,
the levels of HSP90 were also determined. (B) BAX/BAK DKO cells were pre-treated with 1 mM of the JNK inhibitor SP600125 or 10 mM two different
GSK3-b inhibitors (TDZD-8 and L803-mts) for 30 min and then treated with 10 mg/ml Tm or 10 mM Thap under regular growing conditions or in cells
pre-treated for 2 h with media containing 0.5% serum. After 16 h, Annexin-V-FITC staining was evaluated using FACS analysis. Data represents mean
and standard deviation of three determinations. (C) WT and BAX/BAK DKO cells were stably transduced with a pool of lentiviral vectors expressing
different shRNA constructs against Perk mRNA (shPERK) or control shRNA against the luciferase mRNA (shLuc). To determine the efficiency of
knockdown, the level of phospho-PERK, and the downstream targets ATF4 and CHOP were assessed by Western blot in untreated cells (NT) or treated
with 10 mg/ml Tm for 4 h. (D) Cells described in (C) were treated with Tm as described in (B) and cell death was monitored after 20 h by PI staining
and FACS analysis. In addition, WT control cells were stably transduced with shPERK and shLuc lentiviral constructs for comparison in the same
experiments. Data represents the mean and standard deviation of four independent experiments. p values were calculated with Student’s t-test (***:
p,0.001, **: p,0.01 n.s.: non significant).
doi:10.1371/journal.pone.0037782.g005
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Expression
BAX/BAK DKO cells exhibit decreased steady state ER
calcium content due to enhanced calcium leak, with concomitant
resistance to PTP-induced cell death [27]. The ectopic expression
of the ER-calcium pump ATPase SERCA in BAX/BAK DKO
cells restores normal ER calcium levels, enhancing PTP-mediated
apoptosis [27]. We did not observe any effects of SERCA
overexpression in the occurrence of cell death after ER stress and
serum withdrawal treatment in the same cells used in the previous
study [27] (Figure 6A).
To test the role of CypD in the occurrence of BAX/BAK-
independent apoptosis, we reduced the levels of cypD expression in
BAX/BAK DKO cells with an efficient shRNA construct we
recently described and validated [50] (Figure 6B, left panel). Stable
knockdown of cypD mRNA in BAX/BAK DKO cells did not alter
the occurrence of cell death after ER stress stimulation together
with mild serum withdrawal (Figure 6B, right panel; and Figure
S4A). Finally, to rule out the participation of CypD in this BAX/
BAK-independent cell death pathway, we employed triple
knockout (TKO) cells for bax, bak, and cypD (Figure 6C) previously
described [22]. As expected, TKO cells were highly resistant to
ER stress-induced cell death when compared with WT cells
(Figure 6D and Figure S4B). Remarkably, this phenotype was
completely reverted when ER stress stimulation was performed
under conditions of mild serum withdrawal (Figure 6D and Figure
S4B). In addition, the pharmacological inhibitor of cyclophilin D,
cyclosporine A, was also used in our experimental system.
Although DKO cells where not protected against ER stress/
serum withdrawal, WT cells were partially protected against ER
stress when pretreated with cyclosporine A (Figure S5). In
addition, We also tested the impact of the VDAC inhibitor 4,49-
diisothiocyanatostilbene-2,29-disulfonic acid (DIDS) [51,52] on
the death of TKO cells. 500 mM DIDS treatment did not block
the induction of cell death of TKO cells by Tm and serum
withdrawal co-treatments (not shown).
Cell death of TKO cells occurred through apoptosis as
measured by evident cell shrinkage, chromatin condensation
and fragmentation as observed by phase contrast (Figure 6D) or
EM analysis (Figure 6E). Visualization of cells by EM did not
reveal clear signs of mitochondrial swelling in TKO cells
undergoing ER stress and serum withdrawal (Figure 6E). His
observation was confirmed by measurements of mitochondrial
area, perimeter or circularity (Fig. 6F and not shown). Since
cytochrome c release and the engagement of intrinsic apoptosis
of BAX/BAK DKO cells by arachidonic acid and A23187 co-
treatments was reported to be fully blocked by the serine
protease inhibitor 4-(2-Aminoethyl)-benzenesulfonyl fluoride
hydrochloride (AEBSF) [22], we monitored the impact of
AEBSF in our experimental system. Cell death induced by
co-treatment of Tm with mild serum withdrawal was insensitive
to 100 mg/ml AEBSF (Figure 6G). We confirmed the protection
of AEBSF in the induction of cell death by arachidonic acid
plus A23187 in BAX and BAK DKO cells (Figure 6H). Higher
AEBSF concentrations were toxic to the cells (not shown).
Finally, reactive oxygen species are well known mediators of cell
death. Treatment of TKO cells with 1 mM Trolox or 5 mM N-
acetylcysteine (NAC), two potent antioxidants, did not attenuate
the death of TKO cells after Tm and serum withdrawal co-
treatments (Figure 6G). These results suggest that BAX/BAK/
CypD-independent cell death observed in our experimental
system is not regulated by serine proteases.
Discussion
In this article we have identified experimental conditions
where classical intrinsic death stimuli engage the mitochondrial
apoptosis machinery in the absence of BAX, BAK and CypD.
BAX and BAK are fundamental components of the core
apoptosis pathway upon which multiple death signals converge
through activation/upregulation of specific BH3-only proteins to
trigger cytochrome c release [2,3,53,54]. Bax and bak double
deficiency in mice is embryonic lethal due to failure of
developmental programs that depend on apoptosis [4]. Howev-
er, a small percentage of bax and bak DKO mice (,10%) are
viable [4], indicating that proper development can occur in the
absence of these pro-apoptotic proteins. Whether developmental
cell death in the absence of BAX and BAK is dependent on the
CypD and mitochondrial PTP is unknown. We speculate that
this may not be the case since most stimuli that trigger CypD-
induced cell death rely on mitochondrial calcium uptake and
production of reactive oxygen species, conditions more prompt
to undergo necrotic cell death due to a rapid drop in ATP
production. In fact, genetic ablation of cypD does not generate
evident developmental defects, and does not alter the suscep-
tibility to apoptosis of cells to a large number of known intrinsic
death stimuli, but it modulated cell death after exposure to
H2O2 (oxidative stress) in vitro and protected mice against brain
and heart ischemia/reperfusion injury [16,19,55]. Our results,
together with another report [22], suggest the existence of an
alternative mitochondrial regulatory mechanism to instigate
under certain circumstances the release of cytochrome c and
apoptosome assembly in the absence of BAX/BAK and CypD.
Similarly to Tsujimoto’s study [22], we can not exclude the
possibility that Cyclosporin A-insensitive PTP (previously
described in vitro [55]) operates in our experimental system to
trigger cytochrome c release and apoptosis. However we did not
detect any evidence for mitochondrial swelling in our EM
analysis, a key feature of PRP-mediated cell death. A recent
study described the activation of BAX/BAK-independent
apoptosis when cell where deprived of glucose [56]. Apoptosis
induction required RIPK1 and caspase-8 activation, but was
independent of caspase-9 [57].
Irreversible ER stress leads to apoptosis, which requires the
expression of BAX and/or BAK at the mitochondria [30]. Here
we describe conditions in which mild serum withdrawal reestab-
lishes the susceptibility of BAX/BAK DKO MEFs to undergo ER
stress-dependent cell death in an apoptosome-dependent manner.
Cell death was insensitive to BCL-XL overexpression. Similar
results were observed in cells double deficient for the upstream
BH3-only proteins BIM and PUMA, where their resistance to ER
stress was reverted by mild serum withdrawal. Unexpectedly, these
effects were not observed when cell death was triggered with other
intrinsic death stimuli such as DNA damage, inhibition of protein
synthesis, or perturbations of microtubule dynamics, suggesting
that a specific signal emerging from the ER may activate this
alternative intrinsic death pathway.
Since removal of serum from the cell culture media renders
BAX/BAK/CypD TKO cells susceptible to ER stress-induced
apoptosis, we speculate that trophic growth factor signaling may
mask the activity of an alternative pathway to trigger apoptosis in a
BAX/BAK/CypD-independent manner (model in Figure 7).
Insulin/IGF1 signaling has been shown to inhibit cytochrome c
release through activation of AKT, inducing the translocation of
hexokinases to the mitochondrial membrane. Of note, this
pathway controlled the release of cytochrome c even in the
absence of BAX and BAK after exposition to UV light together
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e37782Figure 6. Cell death of BAX and BAK DKO cells is independent of CypD expression. (A) Right panel: BAX/BAK DKO cells stably transfected
with a SERCA expression vector or an empty vector were treated with 10 mg/ml Tm or left untreated (NT) in cells pre-incubated for 2 h with cell
culture media containing 0.5% serum. After 24 h, cell viability was analyzed by PI staining and FACS analysis. Left panel: SERCA expression levels were
determined by Western blot analysis in the two cell lines presented. As loading control HSP90 levels were determined. Data is representative of two
independent experiments. Mean is presented. (B) BAX/BAK DKO cells were stably transduced with lentiviral vectors expressing an shRNA against cypD
mRNA (shCypD) or control shRNA against the luciferase mRNA (shLuc), and the mRNA levels of cypD were determined by real time PCR and
normalized by the levels of beta actin (left panel). Then, in these cells, cell viability was analyzed after treatment with 10 mg/ml Tm in cells grown in
regular cell culture conditions or pre-incubated for 2 h in media containing 0.5% serum. Untreated cells (NT) are also presented. After 24 h cell death
was monitored by PI staining and FACS analysis (right panel). Mean and standard deviation is presented. p value for Tm treatment was calculated
with Student’s t-test in a total of three independent experiments for indicated comparisons. n.s.: non significant (C) Confirmation of the genotype of
BAX/BAK/CypD triple knockout (TKO) cells. Upper panel: The levels of BAX and BAK proteins were monitored by Western blot in TKO and WT control
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in a very small population of cells and with a slow kinetic of
cytochrome c release [58], that is mediated by CypD [59]. We
excluded the participation of this pathway in our experimental
system since we were not able to protect BAX/BAK DKO cells
against Tm/serum withdrawal-induced cell death after stimulating
cells with insulin or IGF1 or treating with Phosphoinositide 3-
kinases (PI3Ks) inhibitors (not shown). It remains to be determined
how growth factor signaling blocks BAX/BAK/CypD-indepen-
dent apoptosis. This inhibitory activity may operate at the level of
the mitochondria to trigger cytochrome c release or it may block a
yet unknown death-signaling event at the level of the ER (Figure 7).
We are currently investigating additional models to uncover the
molecular identity of this intrinsic BAX/BAK/CypD-independent
death pathway. The possible involvement of lipids such as
ceramides in the process constitute an interesting model since
they form large lipid ion-channels in vitro [60] and can also induce
the release of cytochrome c from purified mitochondria [61].
Moreover, ceramides and related lipids could mediate the crosstalk
between ER and mitochondria in the induction of apoptosis in
certain experimental systems [62]. The occurrence of BCL-2
family-independent and CypD-independent apoptosis may be
taken into consideration when therapeutic strategies are designed
to target this group of apoptosis regulators in a disease context,
since depending on the cellular environment (i.e. presence of
particular growth factors), and the cross-talk between different
death signals, the way how apoptosis is regulated may drastically
differ from our classical view of the process.
Materials and Methods
Materials
Tunicamycin (Tm), brefeldin A, thapsigargin, zVAD-fmk,
zIETD-fmk, GSK3 inhibitors and Ruthenium red were purchased
from Calbiochem EMB Bioscience Inc. IGF-1 was purchased from
Australbiologicals and insulin from Actrapid. Cyclosporin A,
etoposide, taxol, PI3K inhibitors, JNK inhibitors, TDZD-8 and
L803-mts, TNF-a and PD98059 were obtained from Calbiochem.
Cell medium, fetal calf serum and antibiotics were obtained from
Life Technologies (Maryland, USA). Hoechst, 3,3-dihexyloxacar-
bocyanine [DIOC6(3)] and fluorescent secondary antibodies were
purchased from Molecular Probes. Nocododazole, actinomycin D
were obtained from Sigma. AEBSF was obtained from Roche.
Cell Culture, Detection of Cell Death and Apoptosis
SV40 transformed MEFs were generated and cultured as
described [29]. BAX and BAK DKO cells expressing SERCA or
mitochondrialtargetedBAXwerepreviouslydescribed[27].BAX/
BAK/cyclophilinDtripleknockoutMEFswerepreviouslydescribed
[22] and were kindly provided by Dr. Tsujimoto. Apoptosis was
determinedbyFACSanalysisofcellsstainedwithAnnexin-VFITC
and Propidium Iodide (Promega) as previously described [29].
AnalysiswasperformedusingtheCellQuestprogram.Hypodiploid
cells were quantified by FACS as previously described [63]. In
parallel, nuclear morphology was analyzed by Hoechst33342
staining (Molecular Probes). To address the impact of serum
withdrawal on ER stress-induced apoptosis, before treatment with
ER stress agents, cells were pre-incubated with cell culture media
containing0.5%serum(fetalcalfserum)for2 handthentreatedwith
brefeldinA,tunicamycinorthapsigargin.Forcaspaseinhibition,cells
were pre-treated with 10 mM zVAD-fmk for 30 min. Alternatively,
cell viability was quantified in 96-well plates using 3-(4,5-
dimethylthazol-2-yl)-5-3-carboxymethoxy-phenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium (MTS) and phenazine methosulfate according
to the recommendations of the supplier (CellTiter 96 AQueous;
Promega,Madison,WI).MitochondriatargetedHA-BAX(mtBAX)
wasconstructedbyfusingthe 29aminoacidmitochondrial targeted
sequence from subunit VIII of human cytochrome c oxidase (COX
VIII) into the N-terminal end of HA-BAX and was present on the
OMM surface [27]. Retroviral expression vectors for HA-tagged
BH3-onlyproteinswerepreviouslydescribed[7].Theproductionof
amphitropic retroviruses using the 293GPG packing cell line was
performed as described previously [29]. Retroviral plasmids were
transfected using Effectene (Qiagene) according to the manufactur-
er’s protocols. Retroviral transduction of each indicated BCL-2
family protein was confirmed by Western blotting using an anti-HA
antibody.
Knockdown of CypD, Caspases-9 and PERK
We generated stable MEFs with reduced levels of cypD, caspases-
9 and perk mRNA using methods previously described [38] by
targeting each mRNA with shRNA using the lentiviral expression
vector pLKO.1 and puromycin selection. As control a shRNA
against the luciferase gene was employed. Constructs were
generated by The Broad Institute (Boston, USA) based on
different criteria for shRNA design (see http://www.broad.mit.
edu/genome_bio/trc/rnai.html). For each gene we screened a
total of five different constructs and selected the most efficient
using real time PCR analysis. We identified the following targeting
sequences for caspase-9 (CCTTTGTTCATCTCCTGCTTA) and
cypD (GCAGAATTGCTTAAAGTCAAA). For knocking down
PERK a mix of five constructs was employed since none of the five
targeting sequences alone were efficient to down regulate PERK.
Targeting sequences are CCTCTACTGTTCACTCAGAAA,
CCATGAGTTCATCTGGAACAA, GCCTGTTTGATGATA-
CAAGTT, CCATACGATAACGGTTACTAT and
GCCACTTTGAACTTCGGTATA.
cells. HSP90 levels were used as loading control. Bottom panel: The cypD null genotype was assessed by PCR using genomic DNA of WT or TKO cells.
PCR fragments corresponding to WT and cypD KO alleles are indicated. (D) Right panel: BAX/BAK/CypD TKO and parental control (WT) cells were
analyzed as described in (B). Data represents mean and standard deviation of six independent experiments performed in duplicates. p value was
calculated with Student’s t-test for indicated comparisons. n.s.: non significant. Left panel: phase contrast images to visualize morphological changes
of TKO cells pre-incubated with cell culture media with 0.5% serum treated or not (NT) with 10 mg/ml Tm. (E) Upper panels: Cell morphology was
monitored in BAX/BAK/CypD TKO cells treated as described in (D) using EM analysis. Arrowheads indicate classical apoptosis morphological features
including chromatin condensation and fragmentations. In addition, cell shrinkage is observed in the analysis. N: nucleus. Lower panels: In the same
cells presented in the upper panel, mitochondrial (M) morphology was visualized. A representative image is presented. (F) The area and circularity of
mitochondria were determined in TKO cells in cells described in (c). Mean and standard deviation is presented of the analysis of 78 (0.5% serum), 105
(Tm) and 112 (Tm +0.5% serum) individual mitochondria per group respectively. (G) TKO cells were pre-treated with 100 mg/ml AEBSF, 1 mM Trolox
or 5 mM N-acetylcysteine (NAC), for 30 min and then treated with 10 mg/ml Tm under regular growing conditions or in cells pre-treated for 2 h with
media containing 0.5% serum. After 16 h, PI staining was evaluated using FACS analysis. (H) As positive control for the use of AEBSF, BAX and BAK
DKO cells were treated with 100 mM arachidonic acid together with 10 mM A23187 in the presence or absence of 100 mg/ml AEBSF, and then after
16 h cell viability analyzed by PI staining and FACS analysis.
doi:10.1371/journal.pone.0037782.g006
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Cells were homogenized by sonication on ice in RIPA buffer
(20 mMTrispH 8.0,150 mM NaCl,0.1%SDS,0.5%DOC,0.5%
tritonX-100)containingaproteaseinhibitorcocktail(Roche,Basel,
Germany), NaF 1 mM, sodium orthovanadate and a phosphatase
inhibitor cocktail (Promega). Protein concentration was determined
by micro-BCA assay (Pierce, Rockford, IL). The equivalent of 30–
50 mgoftotalproteinwasgenerallyloadedonto10%or4–12%SDS-
PAGE minigels (Cambrex) and analyzed by Western blotting. The
following antibodies and dilutions were used: anti-CHOP/
GADD153 1:2000, anti-ATF4 1:2000; anti-XBP-1 1:2000; anti-
JNK1 1:5000 (Santa Cruz); anti-caspase-12 1:3000 (Exalpha
Biologicals),anti-BAXandanti-BAK1:1000(UpstateTechnology);
anti-HA 1:2000 (Roche), anti-caspase-9 1:1000 (Pharmigen), anti-
actin 1:5000 (Chemicon Inc.), anti-SERCA 1:1000 (Affinity Bior-
eagents), anti-HSP90 1:1000 (Santa Cruz Biotechnology) and anti-
pPERK, and p-JNK 1:2000 (Cell Signaling). After incubation with
theprimaryantibodyovernightat4uC,membraneswerewashedand
incubatedfor1 hatroomtemperaturewithhorseradishperoxidase-
coupled secondary antibodies (Amersham Biosciences) diluted
1:5000 in washing buffer. After washing, specifically bound
antibodies were detected by enhanced chemiluminescence assay
(Amersham Biosciences).
Cytochrome c Release, Caspase Activation and
Mitochondrial Membrane Potential Determination
WT, and DKO cells were washed 3 times with cold PBS and
then fixed for 30 min with 4% formaldehyde on ice. Immunoflu-
orescence to detect cytochrome c was performed with methods
previously described [63] using an anti-cytocrome c antibody
(Pharmingen) and fluorescent staining. Then cells were maintained
in PBS containing 0.4% formaldehyde for visualization on a
confocal microscope and analysis with the IP lab v 4.04 software
(Beckon and Dickenson). In cells treated with ER stressors the
mitochondrial membrane potential and cellular volume was
analyzed by flow cytometry (FACS; Becton Dickinson, Mountain
View, CA) after staining of the cells with 2 nM 3,3-dihexylox-
acarbocyanine [DiOC6(3)] (Molecular Probes) [63]. For cleaved
caspase-3 and cleaved caspase-9 immunofluorescence, anti-body
were used 1:250 (#95095 and #96615, Cell signaling). For
mitochondrial and cytochrome C (1:250, BD Pharmigen)
colocalization determinations one focal plane was analyzed. The
images obtained were deconvolved and the background was
subtracted. Colocalization between organelles was quantified using
the Manders algorithm, as previously described [64–66].
Electron Microscopy Analysis
Cells were fixed in 2.5% glutaraldehyde, 0.01% picric acid,
0.1 M cacodylate buffer (pH 7.4) for 1 h, rinsed in the same buffer
and incubated in 1% OsO4 for 30 minutes followed by incubation
with 2% uranyl acetate. Cells were dehydrated with a graded
series of ethanol, and infiltrated with Epon (Ted Pella Inc.,
#18005). Ultrathin sections were contrasted with 1% uranyl
acetate and lead citrate. Grids were examined with a Philips
Tecnai 12 electron microscope operated at 80 kV. Negative films
were developed and scanned.
Figure 7. Working model: A BAX/BAK and CypD-independent intrinsic apoptosis pathway. ER stress-induced apoptosis is mediated by
the activation of BAX and BAK at the mitochondria through upregulation of the upstream BH3-only proteins (i.e. BIM and PUMA) leading to
mitochondrial outer membrane permeabilization, cytochrome c release, and subsequent apoptosome assembling. Under certain conditions such as
mitochondrial calcium overload and oxidative stress, cytochrome c release can occur independently of BAX and BAK through opening of the
mitochondrial permeability transition pore (PTP), which is form by several components including CypD and VDAC. Opening of the PTP leads to the
expansion of the mitochondrial matrix, resulting in sufficient swelling to rupture the outer mitochondrial membrane and cytochrome c release.
Stimulation of ER stress in conjunction with mild serum withdrawal triggers apoptosis in a BAX/BAK and CypD-independent manner. This alternative
death pathway is mediated by the activation of caspase-9. Under normal conditions growth factor signaling may inhibit this alternative cell death
pathway at the level of (i) mitochondria, or by (ii) blocking the activation of a specific ER-dependent event.
doi:10.1371/journal.pone.0037782.g007
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software was used to quantify mitochondrial area, perimeter,
circularity and mean gray value in differents treatments as we
recently described [50].
RNA Extraction and RT-PCR
Total RNA was prepared from cells using trizol (Invitrogen,
Carlsbad, CA) and cDNA was synthesized with SuperScript III
(Invitrogen, Carlsbad, CA) using random primers p(dN)6 (Roche,
Basel, Switzerland). Quantitative real-time PCR reactions employ-
ing SYBR green fluorescent reagent were performed in an ABI
PRISM 7700 system (Applied Biosystems, Foster City, CA). The
relative amounts of mRNAs were calculated from the values of
comparative threshold cycle by using b-actin as control. Primer
sequences were designed by Primer Express software (Applied
Biosystems,FosterCity,CA)orobtainedfromthePrimerDatabank
(http://pga.mgh.harvard.edu/primerbank/index.html). Real time
PCRwasperformedaspreviouslydescribed[38]usingthefollowing
primers: cyclophilin D 59-GGGACAGGTGGCGAAAGTATT-39
and 59-TTCGTATTGGGGCCTGCATTT-39; bim 59-CGA-
CAGTCTCAGGAGGAACC-39 and 59-CATTTGCAAA-
CACCCTCCTT-39; puma 59-GCCCAGCAGCACTTAGAGTC-
39 and 59-GGTGTCGATGCTGCTCTTCT-39; noxa 59-
GGAGTGCACCGGACATAACT-39 and 59-TTGAGCA-
CACTCGTCCTTCA-39; caspases-9,5 9-TCCTGGTACATCGA-
GACCTTG-39and 59-AAGTCCCTTTCGCAGAAACAG-39, ac-
tin 59-TACCACCATGTACCCAGGCA-39 and 5-
‘CTCAGGAGGAGCAATGATCTTGAT-39.
Supporting Information
Figure S1 Serum withdrawal recovers the susceptibility
of BAX and BAK DKO cells to ER stress-induced cell
death. WT MEFs were treated with 10 mg/ml Tm, 10 mM
Thap or 20 mM brefeldin A in cells grown in regular cell culture
media or in media containing 0.5% serum. Mild serum
withdrawal was performed 2 h before the addition of ER stress
agents. After 24 h of treatment, cell viability was analyzed with the
MTS assay. Results are representative of two independent
experiments performed in triplicate. Mean and standard devia-
tions are presented of a representative experiment.
(TIF)
Figure S2 BCL-XL in the control of cytocrome c
redistribution and BH3-only protein expression and
efficiency of retroviral transduction. BAX/BAK DKO
MEFs that stably transduced with retroviruses expressing human
BCL-XL or empty vector (Mock) cells were exposed to 20 mg/ml
Tm in the presence of cell culture media containing 10% serum or
pre-treated with media containing 0.5% serum. After 10 h, cells
were stained with Mitotracker orange (red), fixed and cytochrome
C (Cyt C, green) distribution visualized by indirect immuofluor-
escence. Images were acquired by confocal microscopy. Then,
quantification of the Manders colocalization coefficient MTO/
CytC (fraction of mitrotracker orange signal in co-localizing with
cytochrome C signal) or CytC/MTO (fraction of the cytochrome
C co-localizing mitotracker orange) were analyzed. Data represent
the average and standard deviation of four independent
experiments. One-way ANOVA test was used to analyze statistical
significance (*: p,0.05; **: p,0.01; ***: p,0.01). (B) The
expression of the HA-tagged BH3-only proteins was analyzed by
Western blot after transfection of 293T packaging cells with
pMIG-GFP retroviral vectors together with packaging vector to
produce retroviruses employed in Figure 4F. Red arrowheads
indicate the protein bands corresponding to each BH3-only
protein. A HA-BAX expression vector was also used as control. (B)
The percentage of retroviral transduction efficiency was assessed
in WT and BAX/BAK DKO cells by monitoring the bicistronic
expression of GFP by FACS analysis. Results are representative of
two independent experiments performed in duplicated. Means are
presented of a representative experiment.
(TIF)
Figure S3 LowmRNAlevelsofpro-apoptoticproteinBOK
in WT and BAX/BAK DKO cells. WT and BAX/BAK DKO
cells were treated with 10 mg/ml Tm or left untreated. DKO cells
werealsopre-incubatedfor2 hincellculturemediacontaining0.5%
serum.After6 hoftreatment,bokmRNAlevelswereassessedbyreal
time PCR. As control, the levels of bok mRNA expression were also
monitored inmRNAextracts from mouse ovary.
(TIF)
Figure S4 Cell death in BAX and BAK DKO cells is
independent of CypD. (A) BAX/BAK DKO cells were stably
transduced with lentiviral vectors expressing an shRNA against
cypD mRNA (shCypD) or control shRNA against the luciferase
mRNA (shLuc). Then, cell viability was analyzed after treatment
with 10 mM Thap in cells grown in regular cell culture conditions
or pre-incubated for 2 h in media containing 0.5% serum.
Untreated cells (NT) are also presented. After 24 h cell death
was monitored by PI staining and FACS analysis. (B) WT and
BAX/BAK/CypD TKO cells were treated with 10 mM Thap
under regular cell growing conditions or in cells pre-treated with
media containing 0.5% serum for 2 h. After 24 h, cell death was
analyzed by PI staining and FACS analysis. Mean and standard
deviation are presented of three determinations.
(TIF)
Figure S5 Effect of Cyclosporine A in cell death in WT
and BAX and BAK DKO cells exposed to ER stress. (A)
BAX/BAK WT cells were or not pre-treated with CsA 10 mM for
30 min. Then, cells were incubated with 0.25, 1 and 2,5 mg/mL
Tm for 24 h. Cell viability was analyzed by PI staining and FACS
analysis. Data is representative of three independent experiments.
Mean and standard deviation are presented. Significant differenc-
es were obtained between indicated control and experimental
groups using Student’s t-test (** p,0.01). (B) BAX/BAK DKO
cells were pre-treated with cell culture media containing 0.5%
serum for 2 h in the presence or absence of 1 mM of CsA. Then,
cells were exposed to Tm or Thap for 24 h. Cell viability was
analyzed by PI staining and FACS analysis. Data is representative
of two independent experiments. Mean is presented.
(TIF)
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